Evidence map›Paper›PMID 37789191›Full record

ArticleScientific reports2023

An eXplainable Artificial Intelligence analysis of Raman spectra for thyroid cancer diagnosis.

Loredana Bellantuono, Raffaele Tommasi, Ester Pantaleo, Martina Verri, Nicola Amoroso, Pierfilippo Crucitti, Michael Di Gioacchino, Filippo Longo, Alfonso Monaco, Anda Mihaela Naciu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Loredana BellantuonoDipartimento di Biomedicina Traslazionale e Neuroscienze (DiBraiN), Università degli Studi di Bari Aldo Moro, 70124, Bari, Italy.
Raffaele TommasiDipartimento di Biomedicina Traslazionale e Neuroscienze (DiBraiN), Università degli Studi di Bari Aldo Moro, 70124, Bari, Italy.
Ester PantaleoIstituto Nazionale di Fisica Nucleare, Sezione di Bari, 70125, Bari, Italy.
Martina VerriUnit of Endocrine Organs and Neuromuscolar Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy.
Nicola AmorosoIstituto Nazionale di Fisica Nucleare, Sezione di Bari, 70125, Bari, Italy.
Pierfilippo CrucittiUnit of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy.
Michael Di GioacchinoDipartimento di Scienze, Università degli Studi Roma Tre, 00146, Roma, Italy. michael.digioacchino@uniroma3.it.
Filippo LongoUnit of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy.
Alfonso MonacoIstituto Nazionale di Fisica Nucleare, Sezione di Bari, 70125, Bari, Italy.
Anda Mihaela NaciuUnit of Metabolic Bone and Thyroid Diseases, Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy.
Andrea PalermoUnit of Metabolic Bone and Thyroid Diseases, Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy.
Chiara TaffonUnit of Endocrine Organs and Neuromuscolar Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy.
Sabina TangaroIstituto Nazionale di Fisica Nucleare, Sezione di Bari, 70125, Bari, Italy.
Anna CrescenziUnit of Endocrine Organs and Neuromuscolar Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy.
Armida SodoDipartimento di Scienze, Università degli Studi Roma Tre, 00146, Roma, Italy.
Roberto BellottiIstituto Nazionale di Fisica Nucleare, Sezione di Bari, 70125, Bari, Italy.
Campus Bio Medico University Hospital · ITUniversity of Bari Aldo Moro · ITIstituto Nazionale di Fisica Nucleare, Sezione di Bari · ITRoma Tre University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Raman spectroscopy shows great potential as a diagnostic tool for thyroid cancer due to its ability to detect biochemical changes during cancer development. This technique is particularly valuable because it is non-invasive and label/dye-free. Compared to molecular tests, Raman spectroscopy analyses can more effectively discriminate malignant features, thus reducing unnecessary surgeries. However, one major hurdle to using Raman spectroscopy as a diagnostic tool is the identification of significant patterns and peaks. In this study, we propose a Machine Learning procedure to discriminate healthy/benign versus malignant nodules that produces interpretable results. We collect Raman spectra obtained from histological samples, select a set of peaks with a data-driven and label independent approach and train the algorithms with the relative prominence of the peaks in the selected set. The performance of the considered models, quantified by area under the Receiver Operating Characteristic curve, exceeds 0.9. To enhance the interpretability of the results, we employ eXplainable Artificial Intelligence and compute the contribution of each feature to the prediction of each sample.

Indexed as

Artificial IntelligenceThyroid NeoplasmsAlgorithmsDiagnosis, DifferentialHumansSpectrum Analysis, Raman

Identifiers

PMID37789191
PMCPMC10547772
OpenAlexW4387309807

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.